A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
PK-11195: A POTENTIAL DRUG IN LEUKEMIA TREATMENT
2014
International Research Journal of Pharmacy
Aims of the present work include 1. Qualifying anti-cancer activity of PK-11195 particularly apoptosis inducing effect on Evi1 expressing 3T3-L1 adipocyte cell lines. 2. Identifying the role of Ca III as an antioxidant in Evi1 expressing 3T3-L1 cell lines. 3. Defining the relation of PK-11195's pro-apoptotic activity to its reported inhibitory action on mitochondrial ATPase. Cell Viability was measured by MTT assay. Apoptosis and caspase activation was measured by caspase 3/7 Glo assay. Western
doi:10.7897/2230-8407.050337
fatcat:yyjrfebz75gwlgvin7xj7hjyna